NAROPIN
Google image searchProduct monograph
Active ingredient
ropivacaine hydrochloride, 2 MG/ML
DIN: 02229411
Dosage form(s): SOLUTION
Route(s) of administration: BLOCK/INFILTRATION, EPIDURAL
Schedule: Ethical
Company: ASPEN PHARMACARE CANADA INC.
Date: 28-JUL-2017
ATC:
- N01 — ANESTHETICS (ATC, ATC/DDD, )
- N01B — ANESTHETICS, LOCAL (ATC, ATC/DDD)
- N01BB — Amides (ATC, ATC/DDD)
- N01BB09 — ROPIVACAINE (ATC/DDD)
Reference brand drug: Naropin
Pharmaceutical standard: MFR
